Skip to content

Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease

Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01628731
Enrollment
74
Registered
2012-06-27
Start date
2012-10-31
Completion date
2013-11-30
Last updated
2014-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Overload

Keywords

loop diuretics, fluid balance, urine output, acute renal dysfunction

Brief summary

This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.

Detailed description

Diuretic therapy in children after open heart surgery is widely administered, though no evidence currently supports if an ideal drug or an ideal dosage can be recommended. Loop diuretics are the most effective drugs in terms of urine output production but may cause some collateral effects such as metabolic alkalosis, hypovolemia, hypokalemia, ototoxicity. Furthermore, some reports showed that loop diuretics usage can be associated with an increased risk of renal dysfunction and mortality. However, their use in children with signs of fluid overload, pulmonary edema or oliguria is mandatory and widely practiced. Furosemide and ethacrynic acid are often prescribed and administered without any specific indication, basing on clinicians preferences. No study so far, explored the hypothesis of which of these drugs is the most effective in terms of urine output production and safe in terms of renal function. This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.

Interventions

DRUGfurosemide

furosemide, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours

ethacrynic acid, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours

Sponsors

Bambino Gesù Hospital and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 10 Years
Healthy volunteers
No

Inclusion criteria

* Children with congenital heart disease undergoing cardiac surgery * intraoperative aortic cross clamp over 90 minutes or interventional catheterization procedures with post-operative inotrope score over 20 * sign of fluid retention after surgical procedures

Exclusion criteria

* Preoperative renal dysfunction * Preoperative administration of more than 4mg/kg/die loop diuretics * Need for renal replacement therapy at ICU admission * Need for ECMO at ICU admission

Design outcomes

Primary

MeasureTime frameDescription
Mean total urine output production in the first post-operative dayfirst 24 hours after Intensive Care Unit admissionVerification of the superiority of ethacrynic acid compared with furosemide in improving patients' total urine output by at least 1 ml/kg/h in the first 24 post-operative hours

Secondary

MeasureTime frameDescription
Mean creatinine and NGAL valuesfirst 72 hours after Intensive Care Unit admissionVerification of the superiority of ethacrynic acid compared with furosemide in improving patients' renal function (asessed as creatinine, NGAL and pRIFLE score) in the first 72 post-operative hours

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026